Skip to main content
Clinical Trials/NL-OMON38703
NL-OMON38703
Withdrawn
Not Applicable

Clinical and neurobiological characterisation of muscarinic receptor-deficit schizophrenia (MRDS) - neuroimaging of MRDS

niversiteit Maastricht0 sites90 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
MRDS
Sponsor
niversiteit Maastricht
Enrollment
90
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \-Patients with first\-episode psychosis as defined by the standardised criteria of the CASH
  • \-Antipsychotic naïve
  • \-Duration of untreated psychosis no more than 1 year.
  • \-16 years and older

Exclusion Criteria

  • \-Use of antipsychotics or anticholinergics
  • \-Contraindications for MRI
  • \-Severe neurological, endocrine or psychiatric disorders
  • \-Pregnancy
  • \-Current use of recreational drugs; participants must be abstinent of recreational drugs such as cannabis at least 4 weaks prior to participation.
  • \-Tardive dyskinesia

Outcomes

Primary Outcomes

Not specified

Similar Trials